Weight regain after liraglutide, semaglutide or tirzepatide interruption: A narrative review of randomized studies
Not just in speed of uptake, but in consistency of plasma levels and ease of repeated administration
Strengths Easy, polished onboarding Structured long-term curriculum Well-built tracking app Trade-offs Less individualized than a labs-driven protocol Total cost can be unclear up front No bundled labs, wearables, or supplements Found Founds philosophy lines up with how I work as a therapist: we are not chasing a quick fix, we are building new ways of living
By addressing both the medical and behavioral sides of weight loss, patients are better supported in maintaining progress over time
The Evidence Gap: What the Human Data Actually Shows This is where the essay has to be more direct than most of what you will read online
PT-141 is a cyclic hepta-peptide lactam analog of alpha-melanocyte-stimulating hormone (alpha-MSH), with high affinity at melanocortin receptors 3 and 4 (MC3-R and MC4-R)